FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308133161> ?p ?o ?g. }

• W4308133161 endingPage "A141" @default.
• W4308133161 startingPage "A141" @default.
• W4308133161 abstract "Abstract Background The mammalian adrenal cortex is composed of the zona glomerulosa (ZG), zona fasciculata (ZF), and in some species the zona reticularis (ZR). Each layer is characterized by a specific steroidogenic enzyme expression pattern that leads to selective production of mineralocorticoids, glucocorticoids or adrenal androgens. ZG-specific expression of cytochrome P450 aldosterone synthase (Cyp11b2) and aldosterone biosynthesis are renin-angiotensin-dependent processes in which the Gq-signaling pathway is activated by angiotensin II (AngII). Gq-signaling can be exogenously activated using Gq-coupled designer receptors exclusively activated by designer drug (GqDREADD) technology. Using transgenic mice with targeted expression of GqDREADD to the adrenal cortex, we previously demonstrated that short-term receptor activation increased adrenal Cyp11b2 and aldosterone production. Herein, we hypothesized that prolonged activation of mouse adrenal cortex Gq-signaling would exacerbate the aldosterone levels and promote the transdifferentiation of ZF cells to ZG cells. Methods Transgenic AS+/Cre hM3Dq (GqDREADD) female mice were engineered through crossing GqDREADD mice with Cyp11b2-regulated Cre recombinase mice. Mice were placed on a high sodium diet (to suppress physiologic renin) and orally provided the GqDREADD ligand, clozapine N-oxide (CNO; n=10) or control (n=8) for 6 weeks followed by collection of blood and adrenals. Mineralocorticoid levels were quantified using LC-MS/MS. Adrenal RNA was isolated and assessed by RNAseq for transcriptomic changes, and RT-qPCR analysis for ZG- and ZF-specific transcript markers, Cyp11b2 and Cyp11b1 (marker of ZF), respectively. Transcripts for β-catenin (Ctnnb1) and axin-2 (Axin2) (markers of the WNT signaling pathway) were also analyzed. Immunofluorescence (IF) studies examined adrenal expression of Cyp11b1 and Cyp11b2 in mice treated for 1 month. Results CNO treatment caused plasma aldosterone to increase 613-fold from 7.9 ±2.5 pg/mL to 4810.7 ±1110.7 pg/mL (p&lt;0.01). Levels of 18-hydroxycorticosterone increased 70-fold from 144.9 ±22.0 to 10143.2 ±1479.6 pg/mL (p&lt;0.0001). Corticosterone levels were unaffected. RT-qPCR analysis showed adrenal Cyp11b2 transcripts to be 224-fold higher (p&lt;0.0001) in the CNO-treated group while a 30% decrease in Cyp11b1 levels was observed (p&lt;0.01) compared to the controls. IF demonstrated hybrid ZF cells aberrantly expressing both Cyp11b2 and Cyp11b1. Within the normal mouse adrenal, the outer ZG exhibits high WNT/β-catenin (Ctnnb1) activation. To determine if chronic CNO treatment impacted overall adrenal WNT signaling, Ctnnb1 and Axin2 (a downstream β-catenin gene target) were examined. Analysis revealed no statistical difference in Ctnnb1 and Axin2 transcript levels in treated mice. RNAseq revealed that 242 transcripts were increased in adrenals from treated mice, while 109 decreased (&gt;3-fold change; p&lt;0.01). Induced transcripts include Cyp11b2 and its transcriptional regulators, Nr4a1 and Nr4a2. Conclusion Overall, these findings demonstrate that chronic Gq-signaling is sufficient to cause ZF cells to produce aldosterone and express Cyp11b2. The findings also suggest that the adrenocortical WNT signaling pathway is not increased by the activation of Gq-signaling. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m., Monday, June 13, 2022 12:36 p.m. - 12:41 p.m." @default.
• W4308133161 created "2022-11-08" @default.
• W4308133161 creator A5016090747 @default.
• W4308133161 creator A5039743899 @default.
• W4308133161 creator A5045462330 @default.
• W4308133161 creator A5085226848 @default.
• W4308133161 date "2022-11-01" @default.
• W4308133161 modified "2023-09-30" @default.
• W4308133161 title "RF33 | PSAT79 Chronic Activation of Gq-Signaling in the Mouse Adrenal Cortex Disrupts Zonation and Causes Aldosterone Production in the Zona Fasciculata" @default.
• W4308133161 doi "https://doi.org/10.1210/jendso/bvac150.287" @default.
• W4308133161 hasPublicationYear "2022" @default.
• W4308133161 type Work @default.
• W4308133161 citedByCount "0" @default.
• W4308133161 crossrefType "journal-article" @default.
• W4308133161 hasAuthorship W4308133161A5016090747 @default.
• W4308133161 hasAuthorship W4308133161A5039743899 @default.
• W4308133161 hasAuthorship W4308133161A5045462330 @default.
• W4308133161 hasAuthorship W4308133161A5085226848 @default.
• W4308133161 hasBestOaLocation W43081331611 @default.
• W4308133161 hasConcept C126322002 @default.
• W4308133161 hasConcept C134018914 @default.
• W4308133161 hasConcept C155392382 @default.
• W4308133161 hasConcept C170493617 @default.
• W4308133161 hasConcept C198710026 @default.
• W4308133161 hasConcept C2777784954 @default.
• W4308133161 hasConcept C2777977426 @default.
• W4308133161 hasConcept C2778525890 @default.
• W4308133161 hasConcept C2778736161 @default.
• W4308133161 hasConcept C2780178468 @default.
• W4308133161 hasConcept C2780249997 @default.
• W4308133161 hasConcept C2780902042 @default.
• W4308133161 hasConcept C2908929049 @default.
• W4308133161 hasConcept C71315377 @default.
• W4308133161 hasConcept C71924100 @default.
• W4308133161 hasConcept C84393581 @default.
• W4308133161 hasConcept C86803240 @default.
• W4308133161 hasConceptScore W4308133161C126322002 @default.
• W4308133161 hasConceptScore W4308133161C134018914 @default.
• W4308133161 hasConceptScore W4308133161C155392382 @default.
• W4308133161 hasConceptScore W4308133161C170493617 @default.
• W4308133161 hasConceptScore W4308133161C198710026 @default.
• W4308133161 hasConceptScore W4308133161C2777784954 @default.
• W4308133161 hasConceptScore W4308133161C2777977426 @default.
• W4308133161 hasConceptScore W4308133161C2778525890 @default.
• W4308133161 hasConceptScore W4308133161C2778736161 @default.
• W4308133161 hasConceptScore W4308133161C2780178468 @default.
• W4308133161 hasConceptScore W4308133161C2780249997 @default.
• W4308133161 hasConceptScore W4308133161C2780902042 @default.
• W4308133161 hasConceptScore W4308133161C2908929049 @default.
• W4308133161 hasConceptScore W4308133161C71315377 @default.
• W4308133161 hasConceptScore W4308133161C71924100 @default.
• W4308133161 hasConceptScore W4308133161C84393581 @default.
• W4308133161 hasConceptScore W4308133161C86803240 @default.
• W4308133161 hasIssue "Supplement_1" @default.
• W4308133161 hasLocation W43081331611 @default.
• W4308133161 hasLocation W43081331612 @default.
• W4308133161 hasOpenAccess W4308133161 @default.
• W4308133161 hasPrimaryLocation W43081331611 @default.
• W4308133161 hasRelatedWork W1976214281 @default.
• W4308133161 hasRelatedWork W2012531534 @default.
• W4308133161 hasRelatedWork W2017576713 @default.
• W4308133161 hasRelatedWork W2030198042 @default.
• W4308133161 hasRelatedWork W2052041554 @default.
• W4308133161 hasRelatedWork W2072861904 @default.
• W4308133161 hasRelatedWork W2084354321 @default.
• W4308133161 hasRelatedWork W3022706109 @default.
• W4308133161 hasRelatedWork W3157334049 @default.
• W4308133161 hasRelatedWork W4308133161 @default.
• W4308133161 hasVolume "6" @default.
• W4308133161 isParatext "false" @default.
• W4308133161 isRetracted "false" @default.
• W4308133161 workType "article" @default.